Journal article
Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin- piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
A Devine, E Kenangalem, FH Burdam, NM Anstey, JR Poespoprodjo, RN Price, S Yeung
American Journal of Tropical Medicine and Hygiene | AMER SOC TROP MED & HYGIENE | Published : 2018
Abstract
Artemisinin combination therapy is recommended for the treatment of multidrug resistant Plasmodium falciparum and Plasmodium vivax. In March 2006, antimalarial policy in Indonesia was changed to a unified treatment with dihydroartemisinin-piperaquine for all species of malaria because of the low efficacy of previous drug treatments. In 2013, a randomized cross-sectional household survey in Papua was used to collect data on demographics, parasite positivity, treatment-seeking behavior, diagnosis and treatment of malaria, and household costs. Results were compared with a similar survey undertaken in 2005. A total of 800 households with 4,010 individuals were included in the 2013 survey. The pr..
View full abstractGrants
Awarded by Bill and Melinda Gates Foundation
Funding Acknowledgements
The study was funded by the Wellcome Trust (ICRG Wellcome Trust-ME928457MES and Senior Fellowship in Clinical Science awarded to R. N. P.-200909) and Australian National Health and Medical Research Council (NHMRC #283321). A. D. is funded by the Bill & Melinda Gates Foundation (OPP1054404). The Timika Research Facility and Papuan Community Health Foundation are supported by an NHMRC Program Grant (1037304) and funding from the Australian Department of Foreign Affairs and Trade. S. Y. is supported by the Tracking Resistance to Artemisinins Collaboration (TRAC) programme grant from UKAID. N. M. A. is supported by a NHMRC Practitioner Fellowship (#1042072).